Home › NDC Lookup › RxCUI directory › RxCUI 1728055

5 ML palonosetron 0.05 MG/ML Injection — RxCUI 1728055

RxNorm drug concept · Semantic clinical drug
RxCUI 1728055 Semantic clinical drug · SCD ● Current RxNorm concept 19 FDA products 23 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1728055
Official name5 ML palonosetron 0.05 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aspalonosetron 0.25 MG per 5 ML Injection; palonosetron 0.25 MG in 5 ML Injection
FDA products mapped19
Package NDCs mapped23
Reported Medicaid activity (SDUD)102,945 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Palonosetron Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It's an anti-nausea medicine given through an IV by your healthcare team. It's used to prevent nausea and vomiting that chemotherapy can cause — both the kind that hits within the...
  • What is palonosetron injection (Posfrea) actually used for?
  • You'll always receive this in a clinical setting — a hospital, infusion center, or surgical suite. A nurse or other healthcare professional gives it as an IV infusion or injection....
  • Will I receive this at home, or does it have to be given by a healthcare provider?
📖 Read our full Palonosetron Injection guide →

🕸️ Concept Web — How 5 ML palonosetron 0.05 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 5 ML palonosetron 0.05 MG/ML Injection RxCUI 1728055

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Palonosetron 70561
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Posfrea 2688833
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Palonosetron Injection 1728049
    • Palonosetron Injectable Product 1160714
    • Palonosetron Injection [Posfrea] 2688836
    • Posfrea Injectable Product 2688835
    • Injection 1649574
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Palonosetron 0.05 MG/ML SCDC · 405781
  • Palonosetron Injection SCDF · 1728049
  • Palonosetron Injectable Product SCDG · 1160714

Brand-Name Concepts

📦 FDA Products & Package NDCs

19 products · 23 package NDCs
23 package NDCs map to RxCUI 1728055 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00703-4094-01 1 VIAL, SINGLE-USE in 1 CARTON (0703-4094-01) / 5 mL in 1 V... Palonosetron Hydrochloride Teva Parenteral Medicines, Inc. 2018-03-23
00781-3312-75 1 VIAL, SINGLE-DOSE in 1 CARTON (0781-3312-75) / 5 mL in 1... Palonosetron Hydrochloride Sandoz Inc 2018-03-23
00781-3312-95 10 VIAL, SINGLE-DOSE in 1 CARTON (0781-3312-95) / 5 mL in 1... Palonosetron Hydrochloride Sandoz Inc 2024-10-01
00781-3415-75 1 VIAL, SINGLE-DOSE in 1 CARTON (0781-3415-75) / 5 mL in 1... Palonosetron Hydrochloride Sandoz Inc 2018-11-26
00781-3415-95 10 VIAL, SINGLE-DOSE in 1 CARTON (0781-3415-95) / 5 mL in 1... Palonosetron Hydrochloride Sandoz Inc 2024-10-01
16714-0834-01 1 VIAL, SINGLE-USE in 1 CARTON (16714-834-01) / 5 mL in 1 V... Palonosetron NorthStar Rx LLC 2018-05-29
25021-0783-05 1 VIAL in 1 CARTON (25021-783-05) / 5 mL in 1 VIAL palonosetron hydrochloride Sagent Pharmaceuticals 2018-06-15
36000-0326-02 1 VIAL in 1 CARTON (36000-326-02) / 5 mL in 1 VIAL (36000-3... Palonosetron Hydrochloride Baxter Healthcare Corporation 2021-11-12
55111-0694-07 1 VIAL, SINGLE-USE in 1 CARTON (55111-694-07) / 5 mL in 1 V... Palonosetron Dr.Reddy's Laboratories Limited 2018-03-23
55111-0694-19 5 VIAL, SINGLE-USE in 1 CARTON (55111-694-19) / 1.5 mL in 1... Palonosetron Dr.Reddy's Laboratories Limited 2018-03-23
55150-0186-05 1 VIAL, SINGLE-USE in 1 CARTON (55150-186-05) / 5 mL in 1 V... Palonosetron Hydrochloride Eugia US LLC 2018-11-06
60505-6193-01 1 VIAL in 1 CARTON (60505-6193-1) / 5 mL in 1 VIAL Palonosetron Apotex Corp. 2018-09-19
60505-6193-04 10 VIAL in 1 CARTON (60505-6193-4) / 5 mL in 1 VIAL Palonosetron Apotex Corp. 2018-09-19
60505-6439-01 1 VIAL in 1 CARTON (60505-6439-1) / 5 mL in 1 VIAL Palonosetron Apotex Corp. 2025-10-31
63323-0673-05 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-673-05) / 5 mL in 1... PALONOSETRON Fresenius Kabi USA, LLC 2018-09-19
67184-0514-01 1 VIAL in 1 CARTON (67184-0514-1) / 5 mL in 1 VIAL Palonosetron Qilu Pharmaceutical Co., Ltd. 2018-09-19
67184-0515-02 5 VIAL in 1 CARTON (67184-0515-2) / 1.5 mL in 1 VIAL (67184... Palonosetron Qilu Pharmaceutical Co., Ltd. 2018-09-19
67457-0317-25 1 VIAL, SINGLE-DOSE in 1 CARTON (67457-317-25) / 5 mL in 1... Palonosetron Hydrochloride Mylan Institutional LLC 2018-09-20
68001-0355-25 1 VIAL, SINGLE-USE in 1 CARTON (68001-355-25) / 5 mL in 1 V... Palonosetron BluePoint Laboratories 2018-05-30
69097-0927-35 1 VIAL in 1 CARTON (69097-927-35) / 5 mL in 1 VIAL palonosetron hydrochloride Cipla USA Inc. 2018-03-23
71288-0409-05 1 VIAL, SINGLE-DOSE in 1 CARTON (71288-409-05) / 5 mL in 1... Palonosetron Hydrochloride Meitheal Pharmaceuticals Inc. 2023-08-14
83634-0777-05 1 VIAL, SINGLE-DOSE in 1 CARTON (83634-777-05) / 5 mL in 1... Palonosetron Hydrochloride Avenacy, Inc. 2024-05-15
83831-0105-01 1 VIAL, SINGLE-DOSE in 1 CARTON (83831-105-01) / 5 mL in 1... posfrea Avyxa Pharma, LLC 2024-09-30
Observed labelers: Sandoz Inc (4) · Apotex Corp. (3) · Dr.Reddy's Laboratories Limited (2) · Qilu Pharmaceutical Co., Ltd. (2) · Avenacy, Inc. (1) · Avyxa Pharma, LLC (1) · +10 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J2469 Palonosetron hcl 18 CMS
J2468 Inj, palonosetron (posfrea) 1 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.